Data / Drug companies / Sumatriptan succinate
Sumatriptan succinate: 24 companies and 65 products in the FDA NDC directory
Sumatriptan succinate is listed in the FDA National Drug Code Directory by 24 companies, with 65 products in commercial distribution. 64 of the products (98.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, film coated; injection, and the newest product started marketing on November 6, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 24
- Products
- 65
- Generic (ANDA) products
- 64 (98.5%)
- Application numbers
- 12
- Routes
- Oral, Subcutaneous
- Brand names
- Sumatriptan, Zembrace SymTouch
- openFDA record search
- api.fda.gov
Companies that list sumatriptan succinate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 7 | tablet | Generic drugs (ANDA) | June 18, 2018 |
| Proficient Rx LP | 6 | tablet | Generic drugs (ANDA) | November 17, 2009 |
| A-S Medication Solutions | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | August 17, 2009 |
| Asclemed USA, Inc. | 4 | tablet | Generic drugs (ANDA) | November 17, 2009 |
| Dr. Reddy's Laboratories Limited | 4 | tablet; injection | Generic drugs (ANDA) | February 24, 2014 |
| Sportpharm LLC | 4 | tablet; injection | Generic drugs (ANDA) | April 20, 2023 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | August 17, 2009 |
| Direct_Rx | 3 | tablet, film coated | Generic drugs (ANDA) | December 2, 2024 |
| Golden State Medical Supply, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | August 10, 2009 |
| Mylan Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | August 10, 2009 |
| NorthStar Rx LLC | 3 | tablet | Generic drugs (ANDA) | June 18, 2018 |
| Preferred Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | October 24, 2016 |
| Proficient Rx LP | 3 | tablet, film coated; injection | Generic drugs (ANDA) | August 10, 2009 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | August 10, 2009 |
| Alembic Pharmaceuticals Inc. | 2 | injection | Generic drugs (ANDA) | November 6, 2025 |
| Alembic Pharmaceuticals Limited | 2 | injection | Generic drugs (ANDA) | November 6, 2025 |
| Dr. Reddy's Laboratories Inc. | 1 | injection | Generic drugs (ANDA) | April 20, 2023 |
| Fresenius Kabi USA, LLC | 1 | injection | Generic drugs (ANDA) | April 12, 2011 |
| NorthStar RxLLC | 1 | injection | Generic drugs (ANDA) | June 13, 2023 |
| Quality Care Products, LLC | 1 | tablet | Generic drugs (ANDA) | February 4, 2021 |
| Remedyrepack Inc. | 1 | tablet | Generic drugs (ANDA) | May 14, 2018 |
| Sun Pharmaceutical Industries, Inc. | 1 | injection | Generic drugs (ANDA) | August 20, 2025 |
| Tonix Medicines, Inc. | 1 | solution | New drug applications (NDA) | July 1, 2023 |
| Xellia Pharmaceuticals USA LLC | 1 | injection | Generic drugs (ANDA) | January 1, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 37 | 56.9% |
| Tablet, film coated | 15 | 23.1% |
| Injection | 12 | 18.5% |
| Solution | 1 | 1.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 64 | 98.5% |
| New drug applications (NDA) | 1 | 1.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Serotonin-1b and Serotonin-1d Receptor Agonist | 65 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.